ArticleNeoplasia (New York, N.Y.)2014

Chronic pancreatitis and systemic inflammatory response syndrome prevent impact of chemotherapy with gemcitabine in a genetically engineered mouse model of pancreatic cancer.

Richard F Knoop et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.